4
Changes in Ownership
Processa Pharmaceuticals, Inc. Filed Acc 0000897069-25-001213
Options or other derivatives
- Chief Executive Officer acquired 1,822,471 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Ng George K Chief Executive Officer | 2025-07-24 | Grant or award · Restricted Stock Units | +1,822,471 | 1,922,471 | D | ||
Loading xslF345X05/form4.xml…